首页> 外文期刊>RSC Advances >In silico studies of diarylpyridine derivatives as novel HIV-1 NNRTIs using docking-based 3D-QSAR, molecular dynamics, and pharmacophore modeling approaches
【24h】

In silico studies of diarylpyridine derivatives as novel HIV-1 NNRTIs using docking-based 3D-QSAR, molecular dynamics, and pharmacophore modeling approaches

机译:在二氧化胺研究中的二芳基吡啶衍生物作为新型HIV-1 NNRTIS使用基于对接的3D QSAR,分子动力学和药物模型方法

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel diarylpyridine derivatives has recently been identified as HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs), and most of them exhibited potent activities against HIV-1 strains, with EC50 values in the low nanomolar range. However, the three-dimensional quantitative structure-activity relationships (3D-QSARs) and pharmacophore characteristics of these compounds remain to be studied. In the present study, forty-two diarylpyridine derivatives were firstly docked into HIV-1 reverse transcriptase, and molecular dynamics (10 ns) simulations were further performed to validate the reliability of the docking results, which indicated that residues Lys101, Tyr181, Tyr188, Phe227, and Trp229 might play important roles in binding with these diarylpyridines. The U-shaped docking conformations of all compounds were then used to construct 3D-QSAR and pharmacophore models. The satisfactory statistical parameters of CoMFA (q(loo)(2) = 0.665, r(ncv)(2) = 0.989, r(pred)(2) = 0.962, etc.) and CoMSIA (q(loo)(2) = 0.727, r(ncv)(2) = 0.988, r(pred)(2) = 0.912, etc.) models demonstrated that both constructed models had excellent predictability, and their contour maps gave insights into the structural requirements of the diarylpyridines for the anti-HIV-1 activity. A docking-conformation-based pharmacophore model, containing three hydrophobic centers, three hydrogen-bond acceptors, and three hydrogen-bond donors, was also established. The observations in this study might provide important information for the rational design and development of novel HIV-1 NNRTIs.
机译:最近已经鉴定为HIV-1非核苷逆转录酶抑制剂(NNRTIS)的一系列新的二芳基吡啶衍生物,并且它们中的大多数具有针对HIV-1菌株的有效活性,EC50在低纳米摩尔范围内具有EC50值。然而,仍然研究这些化合物的三维定量结构 - 活性关系(3D-qsars)和药物团特性。在本研究中,首先将四十二个二芳基吡啶衍生物衍生物进入HIV-1逆转录酶,进一步进行分子动力学(10ns)模拟以验证对接结果的可靠性,这表明残留物Lys101,Tyr181,Tyr188, PHE227和TRP229可能在与这些二芳基赖氨酸结合时发挥重要作用。然后使用所有化合物的U形对接构象构建3D QSAR和药物模型。 COMFA(Q(LOO)(2)= 0.665,R(NCV)(2)= 0.989,R(PREG)(2)= 0.962等)和COMSIA(Q(LOO)(2)(2))的令人满意的统计参数= 0.727,R(NCV)(2)= 0.988,R(P7)= 0.912等)模型表明,两种构造的模型具有出色的可预测性,并且它们的轮廓图对二芳基吡啶的结构要求进行了洞察力抗HIV-1活性。还建立了含有三种疏水中心,三种氢粘合受体和三种氢键供体的对接构象的药物综合模型。本研究的观察可能提供新型HIV-1 NNRTIS的理性设计和开发的重要信息。

著录项

  • 来源
    《RSC Advances》 |2018年第71期|共15页
  • 作者单位

    Sch Chem Engn &

    Pharm Key Lab Green Chem Proc Minist Educ Wuhan Hubei 430205 Peoples R China;

    Sch Chem Engn &

    Pharm Key Lab Green Chem Proc Minist Educ Wuhan Hubei 430205 Peoples R China;

    Sch Chem Engn &

    Pharm Key Lab Green Chem Proc Minist Educ Wuhan Hubei 430205 Peoples R China;

    Sch Chem Engn &

    Pharm Key Lab Green Chem Proc Minist Educ Wuhan Hubei 430205 Peoples R China;

    Sch Chem Engn &

    Pharm Key Lab Green Chem Proc Minist Educ Wuhan Hubei 430205 Peoples R China;

    Sch Chem Engn &

    Pharm Key Lab Green Chem Proc Minist Educ Wuhan Hubei 430205 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号